Skip to main content
OpenTrials

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

609 public trials 216 recruiting studies
Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Completed

Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer

NCT02635672

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +65 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
  • Maryland Oncology Hematology Silver Spring, Maryland, United States
  • John Theurer Cancer Center Hackensack, New Jersey, United States
View all 16 locations
View Trial Details
Completed

First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours

NCT04504669

Conditions
Adenocarcinoma, Advanced Solid Tumours, Breast Diseases, +48 more
Locations
  • Research Site Baltimore, Maryland, United States
  • Research Site St Louis, Missouri, United States
  • Research Site Huntersville, North Carolina, United States
  • Research Site Franklin, Tennessee, United States
View all 13 locations
View Trial Details
Completed

PhI to Solid Tumors and PhII to Locally Advanced or mTNBC

NCT05390710

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +6 more
Locations
  • The first affiliated hopsital of bengbu medical college Bengbu, Anhui, China
  • Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Sun Yat-sen Memorial Hospital Guangzhou, China
  • Sir RunRun Shaw Hospital Zhejiang University School of Medicine Hangzhou, China
View Trial Details
Completed

Ipatasertib Plus Non-Taxane Chemotherapy for Advanced or Metastatic Triple-Negative Breast Cancer

NCT04464174

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • Champalimaud Clinical Centre - Champalimaud Foundation Lisbon, Portugal
  • Instituto Português de Oncologia do Porto FG, EPE (IPO-Porto) Porto, Portugal
  • Hospital Provincial de Castellón Castellon, Castellón, Spain
  • Hospital Clínico Universitario Virgen de la Arrixaca El Palmar, Murcia, Spain
View all 14 locations
View Trial Details
Completed

Study of Imprime PGG and Pembrolizumab in Advanced Melanoma and Triple Negative Breast Cancer

NCT02981303

Conditions
Advanced Melanoma, Breast Diseases, Breast Neoplasms, +6 more
Locations
  • Arizona Center for Cancer Care Avondale, Arizona, United States
  • John Wayne Cancer Institute Santa Monica, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Sarah Cannon Research Institute Denver, Colorado, United States
View Trial Details

Related conditions